Type 2 diabetes in primary care: Managing our vulnerable patients through the pandemic and beyond | Diabetes on the Net

Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

This promotional webcast series has been developed, organised and funded by Novo Nordisk for healthcare professionals only.

Novo Nordisk treatments may be discussed. Prescribing information will be provided at the meeting.

Type 2 diabetes in primary care: Managing our vulnerable patients through the pandemic and beyond

A series of interactive webcasts for healthcare professionals

Taking place on:

Next event starting shortly. Already registered?

Type 2 diabetes in primary care:
Managing our vulnerable patients through the pandemic and beyond

The measures taken to address the COVID-19 pandemic, including social distancing and minimising contact with people outside the household, have presented psychological challenges for vulnerable people living with type 2 diabetes who are frail or have mental health issues. Join us for a series of three webcasts which aim to discuss the primary care management of these vulnerable patients through the pandemic and beyond. 

Presented by experts in the field, this webinar series will cover three key issues for this population – a discussion of the key primary care considerations during and after the pandemic, the care of the frail person with type 2 diabetes and the impact of anxiety on our patients.

Upcoming events

Managing type 2 diabetes and vulnerable groups: Key considerations for primary care during and after the pandemic

5 minutes

Welcome

15 minutes

The impact of COVID-19 on the delivery of care of people with type 2 diabetes

20 minutes

Improving the care of vulnerable people with type 2 diabetes now and beyond the pandemic

20 minutes

Live Q&A session

Type 2 diabetes and frailty

15 minutes

Welcome and introduction

20 minutes

Addressing treatment targets and care in the frail population: Key points for optimising glycaemic control

5 minutes

Supporting our patients: Practical tips

20 minutes

Live Q&A session

Diabetes and mental health: Assessing the impact of anxiety on our patients

5 minutes

Welcome

10 minutes

Diabetes and anxiety: An overview

20 minutes

Approaches for assessing and treating anxiety in people with diabetes

5 minutes

Supporting our patients: Practical tips

20 minutes

Live Q&A session

Speakers

Richard Holt (2)

Richard Holt

Professor in Diabetes and Endocrinology, Southampton

David Strain

David Strain

Senior Clinical Lecturer, Exeter

Claire Hambling

Claire Hambling

GP, West Norfolk

Su-Down.jpg

Su Down

Nurse Consultant in Diabetes and the Clinical Lead for the Intermediate Diabetes Community Service, Somerset

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Novo Nordisk Limited (Telephone Novo Nordisk Customer Care Centre 0845 6005055). Calls may be monitored for training purposes.

UK21TSM00013 | Date of preparation: March 2021

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.